Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Prodia Widyahusada TbkISX:PRDA -1.17%81 Equity-to-Asset is 0.89 as of Jun. 2026, which is 7% above its 10-year median of 0.83. GuruFocus rates ISX:PRDA with a GF Score™ of 81/100 and a GF Value™ of Rp3,062.45 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 210 Medical Diagnostics & Research companies, PT Prodia Widyahusada Tbk ranks better than 93.33% on this metric.
The historical rank and industry rank for PT Prodia Widyahusada Tbk's Equity-to-Asset or its related term are showing as below:
ISX:PRDA'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.69 Med: 0.83 Max: 0.9
Current: 0.89
During the past 13 years, the highest Equity to Asset Ratio of PT Prodia Widyahusada Tbk was 0.90. The lowest was 0.69. And the median was 0.83.
ISX:PRDA's Equity-to-Asset is ranked better than 93.33% of 210
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.595
vs ISX:PRDA: 0.89
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
PT Prodia Widyahusada Tbk Equity-to-Asset Related Terms
PT Prodia Widyahusada Tbk Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:PRDA vs TMO, DHR, IDXX: Equity-to-Asset Comparison
For the Diagnostics & Research subindustry, PT Prodia Widyahusada Tbk's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Prodia Widyahusada Tbk Equity-to-Asset vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Prodia Widyahusada Tbk's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where PT Prodia Widyahusada Tbk's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
PT Prodia Widyahusada Tbk's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Prodia Widyahusada Tbk (ISX:PRDA) has a Equity-to-Asset of 0.89 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on PT Prodia Widyahusada Tbk and its competitors. This is near median its historical median of 0.83. Over the past decade, PT Prodia Widyahusada Tbk's Equity-to-Asset has ranged from 0.69 to 0.90. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #14 out of 210 companies in the Medical Diagnostics & Research industry, placing it in the top 6.7%.
Is PT Prodia Widyahusada Tbk's Equity-to-Asset too high?
PT Prodia Widyahusada Tbk's current Equity-to-Asset of 0.89 is near median its 10-year median of 0.83. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 0.90. The Medical Diagnostics & Research industry median Equity-to-Asset is 0.60. PT Prodia Widyahusada Tbk's value of 0.89 is 49.6% above this industry median. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #14 out of 210 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's Equity-to-Asset compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #14 out of 210 companies for Equity-to-Asset. This places PT Prodia Widyahusada Tbk in the top 7% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.60. PT Prodia Widyahusada Tbk's value of 0.89 is 49.6% above this benchmark. Historically, PT Prodia Widyahusada Tbk's own Equity-to-Asset has ranged from 0.69 to 0.90 over the past decade. While the company's 10-year median is 0.83 vs. the industry median of 0.60, PT Prodia Widyahusada Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Diagnostics & Research company?
The median Equity-to-Asset among Medical Diagnostics & Research companies is 0.60, based on 210 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Prodia Widyahusada Tbk's current Equity-to-Asset of 0.89 is 49.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on PT Prodia Widyahusada Tbk and its competitors. For the Medical Diagnostics & Research industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Prodia Widyahusada Tbk's current Equity-to-Asset is 0.89, which is near median its own 10-year median of 0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk (ISX:PRDA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp3,062.45, compared to a current price of Rp2,530.00 — trading 17.4% below its estimated fair value. The current Equity-to-Asset is 0.89, which is near median its 10-year median of 0.83 and 49.6% above the Medical Diagnostics & Research industry median of 0.60. PT Prodia Widyahusada Tbk's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (ISX:PRDA), the current Equity-to-Asset is 0.89 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Prodia Widyahusada Tbk (ISX:PRDA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk stock appears to be undervalued.
The current stock price of Rp2,530.00 is trading 17.4% below its estimated GF Value™ of Rp3,062.45.
GuruFocus considers PT Prodia Widyahusada Tbk to be Modestly Undervalued.
Key valuation signals for ISX:PRDA:
Equity-to-Asset: 0.89 (near median its 10-year median of 0.83)
GF Value™: Rp3,062.45 vs. price of Rp2,530.00 (17.4% below fair value)
Industry Position: 49.6% above the Medical Diagnostics & Research median (#14 of 210)
No single metric tells the full story. See the ISX:PRDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
81GF Score
Get the complete analysis for ISX:PRDA
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRDA has been successfully added to your 
